Form 4: DENTSPLY SIRONA SVP Gains 9,599 Shares from PRSU Vesting

DENTSPLY SIRONA's SVP, Chief Supply Chain Officer, Robert Anthony Johnson, acquired 9,599 shares of common stock through the vesting of performance-based restricted stock units.

Summary

• Robert Anthony Johnson, SVP, Chief Supply Chain Officer of DENTSPLY SIRONA Inc. (XRAY), acquired 9,599 shares of common stock.
• The acquisition resulted from the vesting of performance-based restricted stock units (PRSUs) granted on March 3, 2023.
• The PRSUs were certified as attained on March 2, 2026, after the company met certain performance criteria.
• Following this transaction, Johnson beneficially owns 125,912.146 shares of DENTSPLY SIRONA common stock.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event, indicating successful achievement of performance targets and increased insider ownership, which generally aligns management incentives with shareholder interests.

Positives

• The vesting of 9,599 performance-based restricted stock units indicates that DENTSPLY SIRONA met specific performance criteria.
• This transaction increases the insider's direct ownership in the company, aligning management and shareholder interests.

Future Outlook

The filing does not provide specific forward-looking statements or guidance regarding the company's future performance, focusing solely on an insider's stock transaction.

Industry Context

StockSavvy.ai notes that the vesting of performance-based equity awards is a standard practice in executive compensation across various industries, designed to incentivize long-term performance and align executive interests with shareholder value creation. This particular transaction reflects the successful achievement of internal performance metrics by DENTSPLY SIRONA.

Stakeholder Impact

• Shareholders: Increased alignment of executive interests with shareholder value due to higher insider ownership.
• Employees: Demonstrates the company's commitment to performance-based compensation for its executives.

Key Dates

Recommendation

This Form 4 filing reports a routine insider transaction involving the vesting of performance-based restricted stock units. While it indicates that the company met certain performance criteria, it does not provide new fundamental information about the company's financial health, strategic direction, or market position that would warrant a change in investment recommendation. It primarily reflects an expected compensation event for an executive.

Keywords

DENTSPLY SIRONA, XRAY, Insider Transaction, Form 4, Restricted Stock Units, Performance Shares, Executive Compensation, Stock Vesting